VANCOUVER, Oct. 1 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO), a
reprofiling company focused on redosing or reformulating drugs with clinical
history for new or expanded indications, is pleased to announce that iCo has
been selected as one of Canada's Top 10(TM) Competition winners. Top 10(TM)
winners are chosen by an independent expert panel of Canadian and U.S. venture
capitalists. The panel can be viewed at
http://www.topcanadiancompanies.ca/jury/ls_jury.html.
